<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02634255</url>
  </required_header>
  <id_info>
    <org_study_id>Rocuronium onset</org_study_id>
    <nct_id>NCT02634255</nct_id>
  </id_info>
  <brief_title>The Onset Time of Rocuronium in Emergency and Elective Surgery</brief_title>
  <official_title>The Prospective Randomized Comparison of the Onset Time of Rocuronium in Patients Undergoing Emergency and Elective Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Yildirim Beyazit Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Yildirim Beyazit Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rocuronium, a nondepolarizing neuromuscular blocking agent, is used in general anesthesia to
      provide conditions for endotracheal intubating. Recommended dose is 0,6 mg/kg and 90 seconds
      after intravenous injection, patients can be intubated.

      Anxiety levels may vary in patients undergoing emergency and elective surgery. Patients
      undergoing emergency surgery may display exaggerated laryngoscopic responses. The purpose of
      this study is to investigate the effect of patient anxiety levels on the onset time of
      rocuronium in terms of anxiety scores and train of four (TOF) 0.1 times.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After obtaining ethics committee approval, American Society of Anesthesiologists
      physiological status 1 (ASA 1) patients, undergoing elective inguinal hernia repair and acute
      appendectomy, will be included to trial.

      Patients will be taken to the operating room without premedication. Spielberger's State-Trait
      Anxiety Inventory (STAI) will be administered to patients for determining anxiety level.

      Electrocardiogram, blood pressure and peripheric oxygen saturation (SpO2) will be monitored.
      After opening intravenous access on hand dorsum, ringer lactate solution will be given.
      Neuromuscular monitoring and drug injections will be done as described in &quot;Good Clinical
      Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents&quot;.

      TOF-Guard SX acceleromyograph (Organon-Teknika) will be monitored on corrugator supercilii
      muscle because of its sensitivity to laryngeal muscles. In induction of anesthesia, propofol
      2 mg kg-1 and fentanyl 1 mcg kg-1 will be administered intravenously. After loss of
      conscious, TOF-Guard SX will be calibrated and then 0.6 mg kg-1 rocuronium will be
      administered in 5 seconds. 20 milliampere (mA) current TOF stimulation (200 ms, square wave,
      2 Hz for 1.5 s) will be repeated in every 15 s. Patients will be intubated in TOF 0.1 time.

      STAI score, heart rate, systolic blood pressure, diastolic blood pressure, mean arterial
      pressure, SpO2, TOF 0.1 time and intubation conditions will be compared between two groups.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Train of Four Ratio (TOF 0.1)</measure>
    <time_frame>90 seconds after induction</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>anxiety score</measure>
    <time_frame>15 minutes before induction</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Inguinal Hernia</condition>
  <condition>Acute Appendicitis</condition>
  <arm_group>
    <arm_group_label>Rocuronium elective surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients undergoing inguinal herniorrhaphy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rocuronium emergency surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients undergoing appendectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium elective surgery</intervention_name>
    <description>Rocuronium onset time in patients undergoing inguinal herniorrhaphy</description>
    <arm_group_label>Rocuronium elective surgery</arm_group_label>
    <other_name>esmeron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium emergency surgery</intervention_name>
    <description>Rocuronium onset time in patients undergoing appendectomy</description>
    <arm_group_label>Rocuronium emergency surgery</arm_group_label>
    <other_name>esmeron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <arm_group_label>Rocuronium elective surgery</arm_group_label>
    <arm_group_label>Rocuronium emergency surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <arm_group_label>Rocuronium elective surgery</arm_group_label>
    <arm_group_label>Rocuronium emergency surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ringer Lactate</intervention_name>
    <arm_group_label>Rocuronium elective surgery</arm_group_label>
    <arm_group_label>Rocuronium emergency surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acceleromyography device</intervention_name>
    <arm_group_label>Rocuronium elective surgery</arm_group_label>
    <arm_group_label>Rocuronium emergency surgery</arm_group_label>
    <other_name>TOF Guard Sx</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI 18,5-24,9

          -  ASA 1

        Exclusion Criteria:

          -  Allergy to used drugs during anesthesia

          -  Neuromuscular disease

          -  Liver and kidney failure

          -  Heart failure

          -  Anticipated difficult airway

          -  Using aminoglycosides

          -  BMI&lt;18,5 and BMI&gt;25
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Murat SayÄ±n, Assoc Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Diskapi Yildirim Beyazit Education and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gamze Gulgun, Md</last_name>
    <phone>+905308705073</phone>
    <email>dr.gamzegulgun@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dilek Yazicioglu, Md</last_name>
    <phone>+905336957855</phone>
    <email>dilek.yazicioglu@hotmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J; 8th International Neuromuscular Meeting. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007 Aug;51(7):789-808.</citation>
    <PMID>17635389</PMID>
  </reference>
  <reference>
    <citation>Kain ZN, Mayes LC, Cicchetti DV, Bagnall AL, Finley JD, Hofstadter MB. The Yale Preoperative Anxiety Scale: how does it compare with a &quot;gold standard&quot;? Anesth Analg. 1997 Oct;85(4):783-8.</citation>
    <PMID>9322455</PMID>
  </reference>
  <reference>
    <citation>Plaud B, Debaene B, Donati F. The corrugator supercilii, not the orbicularis oculi, reflects rocuronium neuromuscular blockade at the laryngeal adductor muscles. Anesthesiology. 2001 Jul;95(1):96-101.</citation>
    <PMID>11465590</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2015</study_first_submitted>
  <study_first_submitted_qc>December 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2015</study_first_posted>
  <last_update_submitted>December 15, 2015</last_update_submitted>
  <last_update_submitted_qc>December 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Yildirim Beyazit Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Gamze GULGUN</investigator_full_name>
    <investigator_title>Md</investigator_title>
  </responsible_party>
  <keyword>rocuronium</keyword>
  <keyword>onset time</keyword>
  <keyword>anxiety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
    <mesh_term>Appendicitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>December 13, 2016</submitted>
    <returned>February 3, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

